Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
NCT ID: NCT02737670
Last Updated: 2017-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
126 participants
INTERVENTIONAL
2014-08-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Action of Intra-auricular Topical Lidocaine on Tinnitus
NCT05711641
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214
Study of BGG492 in Patients With Chronic Subjective Tinnitus
NCT01302873
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sulodexide
Sulodexide 25 mg twice per day for 40 days
Sulodexide
25 mg morning and evening for 40 days
Placebo
1 tablet twice per day for 40 days
Placebo
1 tablet morning and evening for 40 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sulodexide
25 mg morning and evening for 40 days
Placebo
1 tablet morning and evening for 40 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of psychiatric or neurological diseases
* Absence of any disease that explains tinnitus
* Noise-induced hearing loss
* Cochlear and retro-cochlear damage
Exclusion Criteria
* Mixed hearing loss
* Meniere's disease
* Systemic vascular disease
* Diabetic disease
* Vestibular schwannoma
* Cerebello-pontine angle tumors
* Pulsatile tinnitus
* Pregnancy
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St Joseph University, Beirut, Lebanon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Joseph Maarrawi
Head of the Laboratory of Neurosciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elias Eter, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine - St Joseph University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Jospeh University
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SULO-TINNITUS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.